Concepedia

Eva Thomas

ET

Statistics

Publications

16

Citations

2.7K

H-Index

14

Active since

2002

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Kaiser Permanente

Cornell University

Breast Cancer Care

Bristol-Myers Squibb (United States)

Eva Thomas is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and breast oncology.

Publications per year

2002–2022

16

Publications

16

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text

, , +17

Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine

Edith A. Perez, Guillermo Lerzo, Xavier Pivot et al. · Journal of Clinical Oncology · 2007 · 393 citations · Full text

, , +15

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

Eva Thomas, Josep Tabernero, Monica Fornier et al. · Journal of Clinical Oncology · 2007 · 290 citations · Full text

, , +15

Total RNA yield and microarray gene expression profiles from fine‐needle aspiration biopsy and core‐needle biopsy samples of breast carcinoma

W. Fraser Symmans, Mark Ayers, Edwin Clark et al. · Cancer · 2003 · 176 citations · Full text

, , +16

Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

Aman U. Buzdar, S. Eva Singletary, Vicente Valero et al. · PubMed · 2002 · 162 citations

, , +17

1–5 of 16